![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
New Program to Improve In-Hospital Atrial Fibrillation Care
25 juin 2012 11h44 HE
|
American Heart Association
News Release Highlights:
The American Heart Association will expand its Get With The Guidelines® quality improvement program to improve the care of patients hospitalized with atrial...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Stroke Risk High When Anti-Clotting Drugs Stopped
25 avr. 2012 13h00 HE
|
American Heart Association
Study Highlights:
Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped.
The risks are similar...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Middle-Aged Men With Upper-Normal Blood Pressure at Risk for AF
17 janv. 2012 16h00 HE
|
American Heart Association
Study Highlights:
Healthy, middle-aged men with upper-normal blood pressure were at increased risk for atrial fibrillation (AF) later in life.
Upper-normal blood pressure at the beginning...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
AHA Perspective on FDA Committee Decision on Rivaroxaban
08 sept. 2011 18h26 HE
|
American Heart Association
DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...